NASDAQ:PRXL - PAREXEL International Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $88.08 0.00 (0.00 %) (As of 10/9/2017)Previous Close$88.08Today's Range$88.08 - $88.0852-Week Range$51.16 - $88.10VolumeN/AAverage Volume1.04 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email PAREXEL International Corporation (PAREXEL) is a biopharmaceutical outsourcing services company. The Company provides a range of expertise in clinical research, clinical logistics, medical communications, consulting, commercialization, and technology products and services to pharmaceutical, biotechnology and medical device industries. Its segments include Clinical Research Services (CRS), PAREXEL Consulting Services (PC) and PAREXEL Informatics (PI). The CRS segment includes various phases of clinical research from first-in-man trials, where a medicinal entity is tested on human subjects for the first time, through post-marketing studies, following approval by the presiding regulatory body. The PC segment provides technical expertise and advice in areas, such as strategy, drug development, regulatory affairs, strategic compliance and targeted communications services in support of product launch. The Company's PI segment provides information technology solutions. Receive PRXL News and Ratings via Email Sign-up to receive the latest news and ratings for PRXL and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryLife Sciences Tools & Services SectorN/A Current SymbolNASDAQ:PRXL Previous Symbol CUSIP69946210 CIK799729 Webwww.parexel.com Phone+1-781-4879900Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable PAREXEL International (NASDAQ:PRXL) Frequently Asked Questions What is PAREXEL International's stock symbol? PAREXEL International trades on the NASDAQ under the ticker symbol "PRXL." Has PAREXEL International been receiving favorable news coverage? News stories about PRXL stock have trended somewhat positive on Monday, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. PAREXEL International earned a media sentiment score of 1.2 on InfoTrie's scale. They also assigned press coverage about the medical research company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near term. What other stocks do shareholders of PAREXEL International own? Based on aggregate information from My MarketBeat watchlists, some companies that other PAREXEL International investors own include Celgene (CELG), Universal Display (OLED), Constellation Brands (STZ), Baidu (BIDU), Gilead Sciences (GILD), Icon (ICLR), Intel (INTC), Jazz Pharmaceuticals (JAZZ), Netflix (NFLX) and NXP Semiconductors (NXPI). Who are PAREXEL International's key executives? PAREXEL International's management team includes the folowing people: Josef H. von Rickenbach, Chairman of the Board, Chief Executive OfficerMark A. Goldberg M.D., President, Chief Operating OfficerSimon Harford, Chief Financial Officer, Senior Vice President, Bio & Compensation - Xavier AB Flinois, President - PAREXEL InformaticsMichelle Graham, Chief Human Resource Officer, Senior Vice PresidentSybrand Pretorius M.D., Senior Vice President, Chief Scientific OfficerDouglas Alexander Batt, Senior Vice President, General Counsel, SecretaryRoland Andersson Ph.d., Senior Vice President - Clinical Research ServicesChristian Dreger Ph.D., Senior Vice President - Parexel Access and Parexel Consulting, Bio & Compensation - David J. Godwin, Senior Vice President-Global Business How do I buy shares of PAREXEL International? Shares of PRXL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is PAREXEL International's stock price today? One share of PRXL stock can currently be purchased for approximately $88.08. What is PAREXEL International's official website? The official website for PAREXEL International is https://www.parexel.com/. How can I contact PAREXEL International? PAREXEL International's mailing address is 195 West St, WALTHAM, MA 02451-1111, United States. The medical research company can be reached via phone at +1-781-4879900. MarketBeat Community Rating for PAREXEL International (NASDAQ PRXL)Community Ranking: 2.1 out of 5 ( )Outperform Votes: 388 (Vote Outperform)Underperform Votes: 517 (Vote Underperform)Total Votes: 905MarketBeat's community ratings are surveys of what our community members think about PAREXEL International and other stocks. Vote "Outperform" if you believe PRXL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRXL will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/22/2019 by MarketBeat.com StaffFeatured Article: Does the discount rate affect the economy?